주식/증권
📉 부정적
Natural Health Stock Slips Post Q2 Earnings, Revenues Decline Y/Y
요약
NHTC's second-quarter 2026 results reflect weak Greater China demand, regulatory uncertainty and Hong Kong disruptions as restructuring lowers costs.